Bilan Wang Selected Research

Bilan Wang Research Topics

Disease

11	Neoplasms (Cancer) 11/2021 - 07/2010
6	Colonic Neoplasms (Colon Cancer) 10/2020 - 01/2011
3	Colorectal Neoplasms (Colorectal Cancer) 06/2019 - 08/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2017
2	Carcinoma (Carcinomatosis) 01/2013 - 01/2011
1	Triple Negative Breast Neoplasms 01/2021
1	Vesicular Stomatitis 10/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Thrombosis (Thrombus) 12/2017
1	Melanoma (Melanoma, Malignant) 12/2017
1	Ischemia 01/2014

Drug/Important Bio-Agent (IBA)

5	methoxy poly(ethylene glycol)-poly(lactide)IBA 10/2020 - 07/2010
4	CurcuminIBA 01/2020 - 01/2013
4	MicellesIBA 12/2017 - 01/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 04/2015
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2017
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020 - 01/2014
2	Interleukin-15 (Interleukin 15)IBA 01/2019 - 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	PolymersIBA 10/2020
1	monomethoxypolyethylene glycol (MPEG)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	taxaneIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	poly(lactide) (polylactic acid)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2019
1	apatinibIBA 06/2019
1	Immunologic Factors (Immunomodulators)IBA 02/2019
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2018
1	AntioxidantsIBA 12/2017
1	SolutionsIBA 12/2017
1	Amyloid (Amyloid Fibrils)IBA 12/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Interleukin-12 (IL 12)IBA 08/2017
1	Ethanol (Ethyl Alcohol)IBA 04/2015
1	cremophor ELIBA 04/2015
1	Therapeutic UsesIBA 01/2014
1	caprolactoneIBA 01/2014
1	Hematoxylin (Haematoxylon)IBA 01/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2014
1	poly(epsilon- caprolactone)- b- poly(ethyleneglycol)- b- poly(epsilon- caprolactone)IBA 01/2014
1	SolventsIBA 01/2013
1	Surface-Active Agents (Surfactants)IBA 01/2013
1	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 01/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2011
1	PolyethyleneimineIBA 01/2011
1	SurvivinIBA 01/2011
1	honokiolIBA 07/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2010

Therapy/Procedure

11	Therapeutics 10/2020 - 07/2010
4	Immunotherapy 11/2021 - 08/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Injections 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 07/2010